CCI-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CCI-001, covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]